Kayıkçıoğlu, E., & Onder, A. H. . (2022). The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors. Chronicles of Precision Medical Researchers, 3(3). https://doi.org/10.5281/zenodo.7195780